US 9193709
1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases
granted A61PA61P25/00A61P25/14
Quick answer
US patent 9193709 (1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases) held by Takeda Pharmaceutical Company Limited expires Mon Nov 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Nov 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61P, A61P25/00, A61P25/14, A61P25/16, A61P25/18